Cambridge-based Mursla Bio, Bicycle Therapeutics and Qureight were among the 12 winners at the 18th annual BioUK Awards announced in a ceremony hosted at the Royal Lancaster Hotel, London. The BioUK Awards were originally known as the OBN Awards when they were…
Alexandria Real Estate looks undervalued versus peers despite 2027 risks. ARE trades at a significant discount to peers. See more details here. - Alexandria Real Estate Equities is rated as undervalued, with fair value estimated at $60 versus a $40.86 close. - 2027 is expected to…
By Kevin Davies, PhD HAMBURG—The historic German port city of Hamburg is playing host to the European Society of Gene & Cell Therapy (ESGCT) conference this week. The statistics remain sobering: More than 40 million people live with HIV, but more…
Nov 19, 2025, 08:06 ET Good Growth Capital together with Meach Cove Capital and other Global Investors Support Next Commercial Milestone Following Successful Honeybee Vaccine Launch; Dalan's European Subsidiary Receives Additional €250K Grant for Pan European Surveillance of Honeybee Diseases As part of the…
Peroxisomes are cell organelles that can cause disease and aging processes if they do not function properly. For the first time ever, University of Groningen researchers have demonstrated that peroxisomes can be created by two independent processes, one of which…
CAMBRIDGE, Mass., Oct. 29, 2026 (GLOBE NEWSWIRE) -- OHB Pediatrics Ltd d/b/a Oak Hill Bio, a clinical-stage rare disease therapeutics company, today announced that the company will participate in the following investor conferences: Oak Hill Bio to Present at Upcoming Investor…
Maria Maccecchini, PhD, CEO of Annovis, will join industry panel with pharma leaders and present company updates U.S. Biotech Day 2026 | November 16–17, 2026 | Philadelphia, PA Panel: "Bridging the Translational Gap: From Discovery Insights to Clinical Proof", November 16, 9:15–9:45 a.m. ET Company showcase: November…
CAMBRIDGE, Mass., October 29, 2026--Metaphore Biotechnologies ("Metaphore"), a Flagship Pioneering company developing antibody medicines designed for the dynamic biology of complex disease, today announced the appointment of Frank D’Amelio and Pascal Deschatelets, Ph.D., as independent directors to the Company’s Board.
Viking Therapeutics faces dilution risk, rising costs, and tough obesity drug competition. Read here for a detailed analysis of VKTX stock. - Viking Therapeutics' maintenance data met upside criteria but failed to excite the market, with shares dropping post-release and dilution…
AdvanSix secures proposed USDA funding to expand ammonia output in Virginia, boosting domestic fertilizer supply. - AdvanSix (ASIX) on Thursday announced it has been selected to receive $47.4 million in proposed funding from the U.S. Department of Agriculture (USDA) through its Fertilizer Investment…
Biotech and Life Sciences: hiring, expansion, leadership and results.
An article joins this feed when it matches these terms. Each one is also a search of its own.